The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
Stefan Hof, Clinical scientist and anesthesiologist at University Hospital of Düsseldorf, shared on LinkedIn:
”Together with our medical doctoral candidate Annalena Müllers we enrolled the first participant in our new clinical study – the CHECK-NIRS study.
In this project, we will systematically investigate external and behavioural factors influencing NIRS-based 2D-imaging.
This marks an important first step in translating our predominantly experimental findings into clinical application, with the goal of gaining deeper insights into tissue oxygenation in humans.
I am particularly looking forward to collaborating with Patricia Wischmann from the Department of Cardiology, Pneumology and Angiology at University Hospital Düsseldorf, Kalman Bodis from the Department of Endocrinology and Diabetology at University Hospital Düsseldorf and Katharina Post from inovex GmbH.
A big thank you to everyone involved for your dedication and teamwork!”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics